Abstract:Purpose: To quantify interfractional anatomical variations and their dosimetric impact during the course of fractionated proton therapy (PT) of prostate cancer and to assess the robustness of the current treatment planning techniques.Methods: Simulation and daily in-room CT scans from ten prostate carcinoma patients were analyzed. PT treatment plans (78 Gy in 39 fractions of 2 Gy) were created on the simulation CT, delivering 25 fractions to PTV1 (expanded from prostate and seminal vesicles), followed by 14 boost fractions to PTV2 (expanded from prostate). Plans were subsequently applied to daily CT, with beams aligned to the prostate center in the sagittal plane. For five patients having a sufficiently large daily imaging volume, structure contours were manually drawn, and plans were evaluated for all CT sets. For the other five patients, the plans were evaluated for six selected fractions. The daily CT was matched to the simulation CT through deformable registration. The registration accuracy was validated for each fraction, and the three patients with a large number of accurately registered fractions were used for dose accumulation.Results: In individual fractions, the coverage of the prostate, seminal vesicles, and PTV1 was generally maintained at the corresponding prescription dose. For PTV2, the volume covered by the fractional prescription dose of 2 Gy (i.e., V2) was, on average, reduced by less than 3% compared to the simulation plan. Among the 225 (39 x 5 + 6 x 5) fractions examined, 15 showed a V2 reduction larger than 5%, of which ten were caused by a large variation in rectal gas, and five were due to a prostate shift in the craniocaudal direction. The fractional dose to the anterior rectal wall was found to increase for one patient who had large rectal gas volume in 25 of the 39 fractions, and another who experienced significant prostate volume reduction during the treatment. The fractional bladder dose generally increased with decreasing fullness. In the total accumulated dose for the three patients after excluding a few fractions with inaccurate registration due to a large amount of rectal gas (a condition inconsistent with RTOG protocol), 98.5%, 96.6%, and 98.2% of the PTV2 received the prescription dose of 78 Gy. The V75 and V70 of the anterior rectal wall and bladder both remained within tolerance.Conclusions: The results confirm that the PT planning techniques and dose constraints used at our institution ensure that target coverage to the prescription dose is maintained in the presence of interfractional anatomical variations. Dose coverage in individual fractions can be compromised, and normal tissue dose increased, due to deviations in the bladder and rectal volume compared to the simulation plans or progressive changes in the prostate volume during the treatment. Deviations from the plan can be reduced with efforts aimed at maintaining consistent daily patient anatomy. (C) 2011 American Association of Physicists in Medicine. [DOI: 10.1118/1.3604152]

Dosimetric equivalence of non-standard high dose rate (HDR) brachytherapy catheter patterns

Comparison of Computed Tomography- and Magnetic Resonance Imaging-Based Target Delineation for Cervical Cancer Brachytherapy

Practical considerations for prostate HDR brachytherapy

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Simultaneous needle catheter selection and dwell time optimization for preplanning of high-dose-rate brachytherapy of prostate cancer

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Dosimetric benefits and preclinical performance of steerable needles in HDR prostate brachytherapy

A Dosimetric Study by Using a Multichannel Cylinder in High-Dose-Rate Brachytherapy Treatment of the Vaginal Cuff

Cancer Of The Cervix: Dosimetric Comparisons Of Dose Prescription To Applicator Point A Versus Dose Prescription To Ctv

Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow

Inverse treatment planning based on MRI for HDR prostate brachytherapy.

A Novel Direction Modulated Brachytherapy Technique for Urethra Sparing in High-Dose-rate Brachytherapy of Prostate Cancer

Dosimetric and Radiobiological Comparison of Volumetric Modulated Arc Therapy, High-dose-rate Brachytherapy and Low-dose-rate Permanent Seeds Implant for Localized Prostate Cancer

Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments

A New CT Prostate Segmentation for CT-based HDR Brachytherapy.

SU-GG-T-73: High Dose Rate (HDR) Brachytherapy Using Foley and Catheter Technique for Treatment of Urethral Cancer

Intensity Modulated High Dose Rate (HDR) Brachytherapy Using Patient Specific 3D Metal Printed Applicators: Proof of Concept

Quality control of high-dose-rate brachytherapy: treatment delivery analysis using statistical process control

Selective dose escalation of regions suspicious for prostate cancer as identified by ultrasonic tissue-type imaging: dosimetric analysis of permanent Pd-103 prostate brachytherapy

Multiparametric MRI-guided Dose Boost to Dominant Intraprostatic Lesions in CT-based High-dose-rate Prostate Brachytherapy

Development of patient and catheter specific error thresholds for high dose rate prostate brachytherapy